Metropolis Healthcare Limited — Updates, 13-05-2025: Press Release

Metropolis Healthcare has announced a board meeting on the financial results for the quarter and half-year. FY25 revenues grew 12% YoY to ₹1,331 Cr, driven by 6% patient and 7% test volume growth. Normalised PAT increased 26% YoY, led by strong performance in TruHealth (24% revenue growth) and Specialty diagnostics (13%). B2C and B2B segments grew 17% and 12%, respectively, with Tier III cities contributing 18% of revenue. Expansion added 29 labs and 400 centers, reaching 750+ towns. Recent acquisitions are set to boost specialty and regional presence further.